Data analytics is a booming market and this company’s IPO could be the biggest since Uber. Continue reading This is Arguably the Most Anticipated Tech IPO of Recent Years
After weeks of euphoric rise, disappointing economic data and fears of a second coronavirus wave are pushing US equities down. Continue reading Stocks Slip on Disappointing Jobs Report and Fears of a Second Coronavirus Wave
Palantir Technologies, one of Silicon Valley’s most secretive and controversial companies, just filed a confidential IPO. Should you invest? Continue reading Silicon Valley’s Most Secretive and Controversial Company May Go Public This Year. Should You Be Terrified or Excited?
Cannabis stocks are not all created equal. Limited moats, heavy governmental taxation and fierce black market competition mean it’s difficult for these companies to generate profits. As this young industry matures, certain companies are emerging as potential best of breed. … Continue reading The 6 Best Cannabis Stocks to Buy in 2020 (and 4 others!)
Here are the dividend stocks I’m looking at this month. Continue reading The Best Dividend Stocks to Buy in July 2020
Legal marijuana sales spiked during the coronavirus. Is this a flash in the pan or proof the industry is on the verge of a bull run? Continue reading Here’s Why It May Be Time to (Finally) Invest in Marijuana Stocks
Despite filing for bankruptcy, Hertz is planning on issuing $1 billion worth of common stock. Is this the Greater Fool Theory at work? Continue reading The “Greater Fool Theory in Action”: Hertz’s Bankruptcy Stock Offering
For the past two months, investors were betting on the reopening of the world’s major economies and the coronavirus being under control. On Thursday, after two and a half months of non-stop gains, the US markets had their worst session … Continue reading Will the Stock Market Crash Again?
On May 15th, 2020, Sorrento Therapeutics (Nasdaq: SRNE) made national headlines when its CEO declared they were developing an antibody cocktail which provides “100% inhibition” of SARS-CoV-2, the virus that leads to COVID-19, in preclinical studies. Henri Ji, Sorrento’s CEO, … Continue reading Here’s Why I’m Not Selling My Sorrento Therapeutics Stock
I love dividends. Specifically, I’m a big fan of Dividend Aristocrats. These are companies who have the enviable track record of increasing their dividend payments at least once a year for the past 25+ years. It’s very rare to find … Continue reading 3 Undervalued Dividend Aristocrats